Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 2/20 | 0.48 |
| ▸ | HRH4 | Q9H3N8 | 10/20 | 0.47 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.44 |
| ▸ | AURKA | O14965 | 2/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.42 |
| ▸ | GPR39 | O43194 | 1/20 | 0.39 |
| ▸ | HEXA | P06865 | 1/20 | 0.37 |
| ▸ | HEXB | P07686 | 1/20 | 0.37 |
| ▸ | IDH1 | O75874 | 1/20 | 0.37 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28265692 | 0.90 | HRH4 (0.46) | NUDT1HRH4TLR8AURKAPDPK1 | |
| SCHEMBL28043759 | 0.87 | HRH4 (0.43) | NUDT1HRH4TLR8AURKAPDPK1 | |
| SCHEMBL28151149 | 0.84 | HRH4 (0.64) | HRH4TLR8AURKAPDPK1TGFBR1 | |
| SCHEMBL28043772 | 0.83 | AURKA (0.54) | NUDT1HRH4TLR8AURKAPDPK1 | |
| SCHEMBL28265745 | 0.82 | HRH4 (0.42) | NUDT1HRH4TLR8AURKAPDPK1 | |
| SCHEMBL28043930 | 0.81 | HRH4 (0.55) | HRH4TLR8AURKAPDPK1TGFBR1 | |
| SCHEMBL28267183 | 0.79 | HRH4 (0.47) | NUDT1HRH4TLR8AURKAPDPK1 | |
| SCHEMBL28152094 | 0.79 | HRH4 (0.54) | HRH4TLR8AURKAPDPK1TGFBR1 | |
| SCHEMBL28845266 | 0.79 | CYP2D6 (0.55) | HRH4TLR8AURKAPDPK1TGFBR1 | |
| SCHEMBL28043727 | 0.78 | HRH4 (0.56) | HRH4TLR8AURKAPDPK1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | disclosed |
| CN-106794181-A | MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions | 托马斯·黑勒戴药物研究基金会 | 2017-05-31 | — | — | CN | disclosed |
| CN-105143206-A | Pyrimidine-2,4-diamine derivatives for treatment of cancer | THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING | 2015-12-09 | — | — | CN | disclosed |